Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hypoxia-inducible factor 1 in autoimmune diseases.
Age-specific localization of NMDA receptors on oligodendrocytes dictates axon function recovery after ischemia.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
What you cannot get from routine MRI of MS patient and why - The growing need for atrophy assessment and seeing beyond the plaque.
Vitamin D in the healthy and inflamed central nervous system: access and function.
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction.
Spatial and temporal characteristics of gait as outcome measures in multiple sclerosis (EDSS 0 to 6.5).
Targeting specific cells in the brain with nanomedicines for CNS therapies.
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: relevance of nicotinic receptors.
Inhibin-a immunoreactivity in nervous system lesions.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Environmental enrichment as a method to improve cognitive function. What can we learn from animal models?
A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.
Neuromyelitis optica (NMO) and autoimmune thyroiditis.
Fatigue, Pain, Anxiety and Depression in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Preliminary Observations on Sensitivity and Specificity of Magnetization Transfer Asymmetry for Imaging Myelin of Rat Brain at High Field.
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects.
Pages
« first
‹ previous
…
718
719
720
721
722
723
724
725
726
…
next ›
last »